Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes

American Journal of Kidney Diseases

Volumn 64, Issue 2, 2014, Pages 278-289

  Cho, Yeoungjee ^a,b   Johnson, David W ^a,b  

^a TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Antibiotics; bacteria; fungi; Index Words; microbiology; outcomes; peritoneal dialysis; peritonitis; practice variation; prevention; quality improvement; risk factors

Indexed keywords

ANTIBIOTIC AGENT; PSEUDOMONIC ACID;

ANTIBIOTIC THERAPY; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HUMAN; PERITONEAL DIALYSIS; PERITONITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); TREATMENT FAILURE;

ANTIBIOTICS; BACTERIA; FUNGI; MICROBIOLOGY; OUTCOMES; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE VARIATION; PREVENTION; QUALITY IMPROVEMENT; RISK FACTORS;

HUMANS; PERITONEAL DIALYSIS; PERITONITIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84905084140     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.02.025     Document Type: Review

References (132)

1. A.K. Jain, P. Blake, P. Cordy, and A.X. Garg Global trends in rates of peritoneal dialysis J Am Soc Nephrol 23 3 2012 533 544
2. Fresenius Medical Care ESRD patients in 2011 - a global perspective http://www.vision-fmc.com/files/download/ESRD/ESRD-Patients-in-2011.pdf 2012 Accessed November 20, 2013
3. J.M. Bargman Advances in peritoneal dialysis: a review Semin Dial 25 5 2012 545 549
4. S.P. McDonald, M.R. Marshall, D.W. Johnson, and K.R. Polkinghorne Relationship between dialysis modality and mortality J Am Soc Nephrol 20 1 2009 155 163
5. Brown F, Gulyani A, McDonald S, Hurst K. Chapter 6: peritoneal dialysis. In: ANZDATA 2012 Annual Report. 35th ed. http://www.anzdata.org.au/anzdata/ AnzdataReport/35thReport/2012c06-peritoneal-v3.pdf. Accessed November 21, 2013.
6. N. Boudville, A. Kemp, and P. Clayton et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis J Am Soc Nephrol 23 8 2012 1398 1405
7. L. Troidle, and F. Finkelstein Treatment and outcome of CPD-associated peritonitis Ann Clin Microbiol Antimicrob 5 2006 6
8. M.C. Brown, K. Simpson, J.J. Kerssens, and R.A. Mactier Encapsulating peritoneal sclerosis in the new millennium: a national cohort study Clin J Am Soc Nephrol 4 7 2009 1222 1229
9. H. Kawanishi, and M. Moriishi Encapsulating peritoneal sclerosis: prevention and treatment Perit Dial Int 27 suppl 2 2007 S289 S292
10. D.W. Johnson, Y. Cho, and B.E. Livingston et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes Kidney Int 77 10 2010 904 912
11. B. Piraino, J. Bernardini, and E. Brown et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections Perit Dial Int 31 6 2011 614 630
12. J.R. Ghali, K.M. Bannister, and F.G. Brown et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients Perit Dial Int 31 6 2011 651 662
13. A. Davenport Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003 Perit Dial Int 29 3 2009 297 302
14. D. Kavanagh, G.J. Prescott, and R.A. Mactier Peritoneal dialysis-associated peritonitis in Scotland (1999-2002) Nephrol Dial Transplant 19 10 2004 2584 2591
15. G. Kopriva-Altfahrt, P. Konig, and M. Mundle et al. Exit-site care in Austrian peritoneal dialysis centers - a nationwide survey Perit Dial Int 29 3 2009 330 339
16. S.H. Han, S.C. Lee, and S.V. Ahn et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center Perit Dial Int 27 4 2007 432 440
17. T.P. Moraes, R. Pecoits-Filho, and S.C. Ribeiro et al. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center Perit Dial Int 29 5 2009 492 498
18. A. Rocha, A. Rodrigues, L. Teixeira, M.J. Carvalho, D. Mendonca, and A. Cabrita Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis Blood Purif 33 4 2012 284 291
19. J.W. Huang, K.Y. Hung, C.J. Yen, K.D. Wu, and T.J. Tsai Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis Nephrol Dial Transplant 16 3 2001 604 607
20. L. Kiernan, A. Kliger, and N. Gorban-Brennan et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems J Am Soc Nephrol 5 10 1995 1835 1838
21. E. Thodis, S. Bhaskaran, P. Pasadakis, J.M. Bargman, S.I. Vas, and D.G. Oreopoulos Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site Perit Dial Int 18 3 1998 261 270
22. J. Bernardini, F. Bender, and T. Florio et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients J Am Soc Nephrol 16 2 2005 539 545
23. W.K. Lo, C.Y. Chan, S.W. Cheng, J.F. Poon, D.T. Chan, and I.K. Cheng A prospective randomized control study of oral nystatin prophylaxis for candida peritonitis complicating continuous ambulatory peritoneal dialysis Am J Kidney Dis 28 4 1996 549 552
24. S.P. McDonald, J.F. Collins, M. Rumpsfeld, and D.W. Johnson Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations Perit Dial Int 24 4 2004 340 346
25. W.H. Lim, D.W. Johnson, and S.P. McDonald Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA Nephrology (Carlton) 10 2 2005 192 197
26. W.H. Lim, N. Boudville, S.P. McDonald, G. Gorham, D.W. Johnson, and M. Jose Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality Nephrol Dial Transplant 26 10 2011 3366 3372
27. G.J. Wanten, P. van Oost, P.M. Schneeberger, and M.I. Koolen Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study Perit Dial Int 16 4 1996 352 356
28. A. Lloyd, N. Tangri, and L.A. Shafer et al. The risk of peritonitis after an exit site infection: a time-matched, case-control study Nephrol Dial Transplant 28 7 2013 1915 1921
29. A.T. van Diepen, G.A. Tomlinson, and S.V. Jassal The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients Clin J Am Soc Nephrol 7 8 2012 1266 1271
30. S.J. Nessim, J.M. Bargman, P.C. Austin, R. Nisenbaum, and S.V. Jassal Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database Clin J Am Soc Nephrol 4 7 2009 1195 1200
31. S. Ros, C. Remon, A.R. Qureshi, P. Quiros, B. Lindholm, and J.J. Carrero Increased risk of fatal infections in women starting peritoneal dialysis Perit Dial Int 33 5 2013 487 494
32. M. Perez Fontan, A. Rodriguez-Carmona, R. Garcia-Naveiro, M. Rosales, P. Villaverde, and F. Valdes Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis Perit Dial Int 25 3 2005 274 284
33. A. Hildebrand, P. Komenda, and L. Miller et al. Peritonitis and exit site infections in First Nations patients on peritoneal dialysis Clin J Am Soc Nephrol 5 11 2010 1988 1995
34. J. Kerschbaum, P. Konig, and M. Rudnicki Risk factors associated with peritoneal-dialysis-related peritonitis Int J Nephrol 2012 2012 483250
35. Y. Cho, S.V. Badve, and C.M. Hawley et al. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes Clin J Am Soc Nephrol 8 9 2013 1556 1563
36. M.A. Bajo, M.L. Perez-Lozano, and P. Albar-Vizcaino et al. Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid Nephrol Dial Transplant 26 1 2011 282 291
37. S.L. Fan, T. Pile, S. Punzalan, M.J. Raftery, and M.M. Yaqoob Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function Kidney Int 73 2 2008 200 206
38. M. Feriani, J. Kirchgessner, G. La Greca, and J. Passlick-Deetjen Randomized long-term evaluation of bicarbonate-buffered CAPD solution Kidney Int 54 5 1998 1731 1738
39. A. Fernandez-Perpen, M.L. Perez-Lozano, and M.A. Bajo et al. Influence of bicarbonate/low-GDP peritoneal dialysis fluid (Bicavera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells Perit Dial Int 32 3 2012 292 304
40. M. Haag-Weber, R. Kramer, and R. Haake et al. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study Nephrol Dial Transplant 25 7 2010 2288 2296
41. D.W. Johnson, F.G. Brown, and M. Clarke et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes J Am Soc Nephrol 23 6 2012 1097 1107
42. D.W. Johnson, F.G. Brown, and M. Clarke et al. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ Trial Perit Dial Int 32 5 2012 497 506
43. S. Kim, J. Oh, W. Chung, C. Ahn, S.G. Kim, and K.H. Oh Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study Nephrol Dial Transplant 24 9 2009 2899 2908
44. J. Pajek, R. Kveder, and A. Bren et al. Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study Nephrol Dial Transplant 24 5 2009 1617 1625
45. B. Rippe, O. Simonsen, and O. Heimburger et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products Kidney Int 59 1 2001 348 357
46. S. Srivastava, S. Hildebrand, and S.L. Fan Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival Kidney Int 80 9 2011 986 991
47. C.C. Szeto, K.M. Chow, C. Lam, and C. Leung et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - a 1-year randomized control trial Nephrol Dial Transplant. 22 2007 552 559
48. A. Tranaeus A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - clinical benefits. The Bicarbonate/Lactate Study Group Perit Dial Int 20 5 2000 516 523
49. L. Weiss, B. Stegmayr, and G. Malmsten et al. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution Perit Dial Int 29 6 2009 647 655
50. S. Bro, J.B. Bjorner, and P. Tofte-Jensen et al. A prospective, randomized multicenter study comparing APD and CAPD treatment Perit Dial Int 19 6 1999 526 533
51. A. Rodriguez-Carmona, M. Perez Fontan, T. Garcia Falcon, C. Fernandez Rivera, and F. Valdes A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis Perit Dial Int 19 3 1999 253 258
52. Y. Cho, S.V. Badve, and C.M. Hawley et al. Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study Nephrol Dial Transplant 27 5 2012 2028 2036
53. R. Miles, C.M. Hawley, and S.P. McDonald et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients Kidney Int 76 6 2009 622 628
54. P.K. Li, C.C. Szeto, and B. Piraino et al. Peritoneal dialysis-related infections recommendations: 2010 update Perit Dial Int 30 4 2010 393 423
55. Lin CY, Roberts GW, Kift-Morgan A, Donovan KL, Topley N, Eberl M. Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients [published online ahead of print October 31, 2013]. J Am Soc Nephrol. http://dx.doi.org/10.1681/ASN.2013040332.
56. M. Burke, C.M. Hawley, and S.V. Badve et al. Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study Am J Kidney Dis 58 3 2011 429 436
57. C.C. Szeto, B.C. Kwan, and K.M. Chow et al. Recurrent and relapsing peritonitis: causative organisms and response to treatment Am J Kidney Dis 54 4 2009 702 710
58. C.C. Szeto, B.C. Kwan, and K.M. Chow et al. Repeat peritonitis in peritoneal dialysis: retrospective review of 181 consecutive cases Clin J Am Soc Nephrol 6 4 2011 827 833
59. T. Thirugnanasambathan, C.M. Hawley, and S.V. Badve et al. Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study Am J Kidney Dis 59 1 2012 84 91
60. Szeto CC, Lai KB, Kwan BC, et al. Bacteria-derived DNA fragment in peritoneal dialysis effluent as a predictor of relapsing peritonitis [published online ahead of print October 3, 2013]. Clin J Am Soc Nephrol. http://dx.doi.org/10.2215/CJN.02360213.
61. B.C. Kwan, K.M. Chow, and C.B. Leung et al. Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis Nephrol Dial Transplant 28 8 2013 2139 2145
62. M.M. El-Naggar, S.A. Khalil el, M.A. El-Daker, and M.F. Salama Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites J Med Microbiol 57 pt 12 2008 1533 1538
63. P. Choi, E. Nemati, A. Banerjee, E. Preston, J. Levy, and E. Brown Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization Am J Kidney Dis 43 1 2004 103 111
64. K.J. Wiggins, D.W. Johnson, J.C. Craig, and G.F. Strippoli Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials Am J Kidney Dis 50 6 2007 967 988
65. K.J. Wiggins, J.C. Craig, D.W. Johnson, and G.F. Strippoli Treatment for peritoneal dialysis-associated peritonitis Cochrane Database Syst Rev 1 2008 CD005284
66. D. Bennett-Jones, V.W. Penny, M.D. Taube, G.N. Chisholm, O.S. Cameron, and D.G. Williams A comparison of intraperitoneal and intravenous/oral antibiotics in CAPD peritonitis Perit Dial Int 7 1 1987 31 33
67. M.K. Chan, I.K. Cheng, and W.S. Ng A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis Am J Kidney Dis 15 2 1990 155 159
68. I.K. Cheng, G.X. Fang, and P.Y. Chau et al. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD Perit Dial Int 18 4 1998 371 375
69. J.S. Tapson, K.E. Orr, J.C. George, E. Stansfield, A.J. Bint, and M.K. Ward A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis J Antimicrob Chemother 26 suppl F 1990 63 71
70. W. Ruger, F.J. van Ittersum, L.F. Comazzetto, S.E. Hoeks, and P.M. ter Wee Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis Perit Dial Int 31 1 2011 39 47
71. Stevenson S, Tang W, Cho Y, et al. The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis [published online ahead of print March 1, 2014]. Perit Dial Int. http://dx.doi.org/10.3747/ pdi.2013.00156.
72. W. Tang, Y. Cho, C.M. Hawley, S.V. Badve, and D.W. Johnson The role of monitoring gentamicin levels in patients with Gram-negative peritoneal dialysis-associated peritonitis Perit Dial Int 34 2 2014 219 226
73. M. Blunden, D. Zeitlin, N. Ashman, and S.L. Fan Single UK centre experience on the treatment of PD peritonitis - antibiotic levels and outcomes Nephrol Dial Transplant 22 6 2007 1714 1719
74. K. Barraclough, C.M. Hawley, and S.P. McDonald et al. Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases Nephrol Dial Transplant 24 12 2009 3834 3839
75. M. Edey, C.M. Hawley, and S.P. McDonald et al. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases Nephrol Dial Transplant 25 4 2010 1272 1278
76. K. Barraclough, C.M. Hawley, and S.P. McDonald et al. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes Am J Kidney Dis 55 1 2010 121 131
77. K.M. Chow, C.C. Szeto, and K.K. Cheung et al. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis Clin J Am Soc Nephrol 1 4 2006 768 773
78. C.C. Szeto, K.M. Chow, and B.C. Kwan et al. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases Clin J Am Soc Nephrol 2 2 2007 245 251
79. C.C. Szeto, V.C. Chow, and K.M. Chow et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases Kidney Int 69 7 2006 1245 1252
80. C.C. Szeto, B.C. Kwan, and K.M. Chow et al. Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases Clin J Am Soc Nephrol 3 1 2008 91 97
81. M. Fahim, C.M. Hawley, and S.P. McDonald et al. Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases Nephrol Dial Transplant 25 10 2010 3386 3392
82. M. Fahim, C.M. Hawley, and S.P. McDonald et al. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases Am J Kidney Dis 55 4 2010 690 697
83. S. Govindarajulu, C.M. Hawley, and S.P. McDonald et al. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases Perit Dial Int 30 3 2010 311 319
84. E.M. Jarvis, C.M. Hawley, and S.P. McDonald et al. Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis Kidney Int 78 4 2010 408 414
85. S. O'Shea, C.M. Hawley, and S.P. McDonald et al. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases BMC Nephrol 10 2009 19
86. B. Siva, C.M. Hawley, and S.P. McDonald et al. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases Clin J Am Soc Nephrol 4 5 2009 957 964
87. G.F. Strippoli, A. Tong, D. Johnson, F.P. Schena, and J.C. Craig Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials J Am Soc Nephrol 15 10 2004 2735 2746
88. P.K. Li, C.C. Szeto, and M.C. Law et al. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study Am J Kidney Dis 33 3 1999 535 540
89. M.F. Gadallah, G. Ramdeen, J. Mignone, D. Patel, L. Mitchell, and S. Tatro Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters Am J Kidney Dis 36 5 2000 1014 1019
90. A.M. Wikdahl, U. Engman, B.G. Stegmayr, and J.G. Sorenssen One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion Nephrol Dial Transplant 12 1 1997 157 160
91. G.F. Strippoli, A. Tong, D. Johnson, F.P. Schena, and J.C. Craig Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients Cochrane Database Syst Rev 4 2004 CD004680
92. S.J. Nessim, J.M. Bargman, and S.V. Jassal Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis Nephrol Dial Transplant 25 7 2010 2310 2314
93. G.F. Strippoli, A. Tong, D. Johnson, F.P. Schena, and J.C. Craig Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients Cochrane Database Syst Rev 4 2004 CD004679
94. No authors listed. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group J Am Soc Nephrol 7 11 1996 2403 2408
95. M. Perez-Fontan, M. Rosales, and A. Rodriguez-Carmona et al. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin Adv Perit Dial 8 1992 242 245
96. D. Sit, A.K. Kadiroglu, H. Kayabasi, and M.E. Yilmaz Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients Adv Ther 24 2 2007 387 393
97. J. Bernardini, B. Piraino, J. Holley, J.R. Johnston, and R. Lutes A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin Am J Kidney Dis 27 5 1996 695 700
98. S.S. Wong, K.H. Chu, and A. Cheuk et al. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site Perit Dial Int 23 suppl 2 2003 S153 S158
99. M. Perez-Fontan, M. Rosales, A. Rodriguez-Carmona, T.G. Falcon, and F. Valdes Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis Am J Kidney Dis 39 2 2002 337 341
100. D.A. Pierce, J.C. Williamson, V.S. Mauck, G.B. Russell, E. Palavecino, and J.M. Burkart The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis Perit Dial Int 32 5 2012 525 530
101. D.W. Johnson, S.V. Badve, and E.M. Pascoe et al. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial Lancet Infect Dis 14 1 2014 23 30
102. R.F. McQuillan, E. Chiu, and S. Nessim et al. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study Clin J Am Soc Nephrol 7 2 2012 297 303
103. J. Bernardini, V. Price, and A. Figueiredo International Society for Peritoneal Dialysis Nursing Liaison C. Peritoneal dialysis patient training, 2006 Perit Dial Int 26 6 2006 625 632
104. K.M. Chow, C.C. Szeto, M.C. Law, J.S. Fun Fung, and P. Kam-Tao Li Influence of peritoneal dialysis training nurses' experience on peritonitis rates Clin J Am Soc Nephrol 2 4 2007 647 652
105. J. Bernardini, V. Price, A. Figueiredo, A. Riemann, and D. Leung International survey of peritoneal dialysis training programs Perit Dial Int 26 6 2006 658 663
106. M. Holloway, S. Mujais, M. Kandert, and B.A. Warady Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates Perit Dial Int 21 4 2001 401 404
107. Y. Cho, D.W. Johnson, S.V. Badve, J.C. Craig, G.F. Strippoli, and K. Wiggins Impact of neutral pH, low glucose degradation product peritoneal dialysis solution on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials Kidney Int 84 5 2013 969 979
108. S.V. Badve, A. Smith, C.M. Hawley, and D.W. Johnson Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients NDT Plus 2 6 2009 508
109. M.D. Jose, D.W. Johnson, and D.W. Mudge et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action Nephrology (Carlton) 16 1 2011 19 29
110. N. Fernandes, M.G. Bastos, and H.V. Cassi et al. The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): characterization of the cohort Kidney Int Suppl 108 2008 S145 S151
111. Y.W. Ho, K.F. Chau, and B.Y. Choy et al. Hong Kong Renal Registry Report 2012 Hong Kong J Nephrol 15 1 2013 28 43
112. F.F. Ersoy Improving technique survival in peritoneal dialysis: what is modifiable? Perit Dial Int 29 suppl 2 2009 S74 S77
113. M. Qamar, H. Sheth, F.H. Bender, and B. Piraino Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives Adv Perit Dial 25 2009 76 79
114. Brown F, on behalf of the Home Dialysis Advisory Committee. Peritoneal dialysis - best practice - peritonitis prevention and management. 2013; http://www.renalsociety.org/temp/PeritonealDialysisHDACpositionStatement-2013. pdf. Accessed November 4, 2013.
115. M.G. Farias, J.M. Soucie, W. McClellan, and W.E. Mitch Race and the risk of peritonitis: an analysis of factors associated with the initial episode Kidney Int 46 5 1994 1392 1396
116. L.C. Martin, J.C. Caramori, and N. Fernandes et al. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients Clin J Am Soc Nephrol 6 8 2011 1944 1951
117. S.H. Han, S.C. Lee, and S.V. Ahn et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients Nephrol Dial Transplant 22 9 2007 2653 2658
118. Y. Cho, S.V. Badve, and C.M. Hawley et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study BMC Nephrol 13 2012 41
119. P.H. Juergensen, D.B. Wuerth, and D.M. Juergensen et al. Psychosocial factors and clinical outcome on CAPD Adv Perit Dial 13 1997 121 124
120. L. Troidle, S. Watnick, D.B. Wuerth, N. Gorban-Brennan, A.S. Kliger, and F.O. Finkelstein Depression and its association with peritonitis in long-term peritoneal dialysis patients Am J Kidney Dis 42 2 2003 350 354
121. K.M. Chow, C.C. Szeto, C.B. Leung, B.C. Kwan, M.C. Law, and P.K. Li A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis Perit Dial Int 25 4 2005 374 379
122. Y.W. Chuang, K.H. Shu, T.M. Yu, C.H. Cheng, and C.H. Chen Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients Nephrol Dial Transplant 24 5 2009 1603 1608
123. T. Yip, K.C. Tse, and M.F. Lam et al. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients Perit Dial Int 27 5 2007 560 564
124. M. Rudnicki, J. Kerschbaum, J. Hausdorfer, G. Mayer, and P. Konig Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin D Perit Dial Int 30 5 2010 541 548
125. D.D. Oygar, A.S. Yalin, M.R. Altiparmak, R. Ataman, and K. Serdengecti Obligatory referral among other factors associated with peritonitis in peritoneal dialysis patients Nefrologia 31 4 2011 435 440
126. S.J. Nessim, J.M. Bargman, P.C. Austin, K. Story, and S.V. Jassal Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect Clin J Am Soc Nephrol 4 1 2009 135 141
127. B. Schiller, M. Alcaraz, K. Hadley, and J. Moran Peritonitis and zoonosis: your best friend sometimes isn't! Perit Dial Int 31 2 2011 127 130
128. R. Russo, L. Manili, and G. Tiraboschi et al. Patient re-training in peritoneal dialysis: why and when it is needed Kidney Int Suppl 103 2006 S127 S132
129. Y. Cho, S.V. Badve, and C.M. Hawley et al. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes Clin J Am Soc Nephrol 8 9 2013 1556 1563
130. M. Flanigan, and R. Gokal Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments Perit Dial Int 25 2 2005 132 139
131. G. Hall, A. Bogan, and S. Dreis et al. New directions in peritoneal dialysis patient training Nephrol Nurs J 31 2 2004 149 154 159-163
132. L. Gadola, C. Poggi, and M. Poggio et al. Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients Perit Dial Int 33 1 2013 38 45